Literature DB >> 20977339

Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections.

Long Fu Xi1, Laura A Koutsky, Philip E Castle, Zoe R Edelstein, Ayaka Hulbert, Mark Schiffman, Nancy B Kiviat.   

Abstract

Prospective studies of the persistence of human papillomavirus (HPV) variants are rare and typically small. We sequenced HPV-16 variants in longitudinal pairs of specimens from 86 women enrolled in the ASCUS-LSIL Triage Study. A change of variants was identified in 4 women (4.7% [95% confidence interval, 1.3%-11.5%]). Among women with intervening HPV results (n = 60), a variant switch occurred in 2 of 11 who had evidence of intervening negativity for HPV-16, compared with 1 of 49 who consistently tested positive (P = .11). These results suggest the possibility that rare misclassification of transient infections as persistent infections occurs in natural history studies of type-specific HPV infections.

Entities:  

Mesh:

Year:  2010        PMID: 20977339      PMCID: PMC3107552          DOI: 10.1086/657083

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Short-term fluctuations in the detection of cervical human papillomavirus DNA.

Authors:  C M Wheeler; C E Greer; T M Becker; W C Hunt; S M Anderson; M M Manos
Journal:  Obstet Gynecol       Date:  1996-08       Impact factor: 7.661

2.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.

Authors:  Long Fu Xi; Nancy B Kiviat; Allan Hildesheim; Denise A Galloway; Cosette M Wheeler; Jesse Ho; Laura A Koutsky
Journal:  J Natl Cancer Inst       Date:  2006-08-02       Impact factor: 13.506

Review 4.  Evolution of papillomaviruses.

Authors:  H U Bernard; S Y Chan; H Delius
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

5.  Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection.

Authors:  E L Franco; L L Villa; P Rahal; A Ruiz
Journal:  J Natl Cancer Inst       Date:  1994-10-19       Impact factor: 13.506

6.  Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix.

Authors:  Soraya Khouadri; Luisa L Villa; Simon Gagnon; Anita Koushik; Harriet Richardson; Silvaneide Ferreira; Pierre Tellier; João Simao; Greg Matlashewski; Michel Roger; Eduardo L Franco; Francois Coutlée
Journal:  J Infect Dis       Date:  2006-08-30       Impact factor: 5.226

7.  Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.

Authors:  M H Mayrand; F Coutlée; C Hankins; N Lapointe; P Forest; M de Ladurantaye; M Roger
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.

Authors:  M Schiffman; M E Adrianza
Journal:  Acta Cytol       Date:  2000 Sep-Oct       Impact factor: 2.319

9.  Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients.

Authors:  A van Belkum; L Juffermans; L Schrauwen; G van Doornum; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

10.  Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection.

Authors:  L F Xi; G W Demers; L A Koutsky; N B Kiviat; J Kuypers; D H Watts; K K Holmes; D A Galloway
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

View more
  8 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.

Authors:  Tsung-Chieh Jane Fu; Joseph J Carter; James P Hughes; Qinghua Feng; Stephen E Hawes; Stephen M Schwartz; Long Fu Xi; Taylor Lasof; Joshua E Stern; Denise A Galloway; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2016-08-04       Impact factor: 7.396

Review 3.  Updating the natural history of human papillomavirus and anogenital cancers.

Authors:  Anna-Barbara Moscicki; Mark Schiffman; Ann Burchell; Ginesa Albero; Anna R Giuliano; Marc T Goodman; Susanne K Kjaer; Joel Palefsky
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

4.  Sequence imputation of HPV16 genomes for genetic association studies.

Authors:  Benjamin Smith; Zigui Chen; Laura Reimers; Koenraad van Doorslaer; Mark Schiffman; Rob Desalle; Rolando Herrero; Kai Yu; Sholom Wacholder; Tao Wang; Robert D Burk
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 5.  Papillomaviruses: Viral evolution, cancer and evolutionary medicine.

Authors:  Ignacio G Bravo; Marta Félez-Sánchez
Journal:  Evol Med Public Health       Date:  2015-01-28

Review 6.  Natural History of HPV Infection across the Lifespan: Role of Viral Latency.

Authors:  Patti E Gravitt; Rachel L Winer
Journal:  Viruses       Date:  2017-09-21       Impact factor: 5.048

7.  Whole-Genome Sequencing and Variant Analysis of Human Papillomavirus 16 Infections.

Authors:  Pascal van der Weele; Chris J L M Meijer; Audrey J King
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

8.  HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis.

Authors:  Colm Mac Eochagain; Robert Power; Imelda Parker; Donal Brennan
Journal:  J Gynecol Oncol       Date:  2022-01-12       Impact factor: 4.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.